BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2018
View Archived Issues
FN-1501 identified as a novel FLT-3 and CDK inhibitor for the treatment of AML
Read More
NIAID initiates phase I study of HIV-1 vaccines
Read More
GSK initiates phase II study of SARM GSK-2881078 in patients with COPD
Read More
Shanghai Pharmaceuticals initiates phase Ia trial with B-001 in patients with NHL
Read More
Insmed submits NDA for ALIS for nontuberculous mycobacterial lung disease
Read More
FDA grants orphan drug designation to Scholar Rock's SRK-015 for SMA
Read More
Catalyst submits NDA for Firdapse for LEMS
Read More
Pharmacokinetics of anti-HIV agent GS-9131 explored in phase I study
Read More
European Commission approves expanded indication for Xgeva
Read More
EMA accepts cemiplimab MAA for cutaneous squamous cell carcinoma
Read More
Symic reports 12-month data from SHIELD trial of SB-030 in peripheral vascular disease
Read More
EMA accepts Dupixent submission in asthma
Read More
First phase I data presented for ACT-709478 in healthy volunteers
Read More
ETC-206, a new agent for hematological cancers
Read More
FDA grants accelerated approval to Blincyto for B-cell precursor ALL with minimal residual disease
Read More
Numerate patents novel FFAR4 agonists
Read More
Roche and Genentech divulge new JAK1 inhibitors
Read More
Calithera Biosciences identifies new CD73 inhibitors
Read More
FDA approves Leukine for H-ARS
Read More
Chinese researchers discover CDK4/6 inhibitors
Read More
Novartis targets kinetoplastid proteasome for Chagas disease, leishmaniasis
Read More
Sunovion submits NDA for APL-130277 to treat off episodes associated with Parkinson's disease
Read More
Albert Einstein College of Medicine patents MSC-derived microvesicles
Read More
Motif Bio initiates rolling NDA for iclaprim
Read More
Compugen and MedImmune sign cancer immunotherapy license agreement
Read More
FDA issues refusal to file letter for Alkermes' ALKS-5461 NDA
Read More
Taiwan Liposome submits IND for TLC-590
Read More